IT'S DIFFICULT to fathom how in this protracted war against the pandemic, the virus, sars-cov-2, has managed every time to gain the upper hand over humanity, its ingenuity and its scientific breakthroughs. In the beginning, the world scrambled to decode the novel virus and its infection strategies and to churn out enough personal protection equipment, hand sanitisers, ventilators and other medical supplies. Then it was the race to develop worthy vaccines in record time. Despite humanity successfully crossing these hurdles, the novel coronavirus disease (COVID-19) continues to rage and the world now stares at yet another challenge of vaccinating everyone well in time.
Consider these numbers. Till April 8, only 711 million jabs had been administered across the world, as per the Johns Hopkins University, US. This has ensured complete inoculation of a little more than 2 per cent of the world’s adult population. According to data analytics company Airfinity, the world will manufacture 9.5 billion doses by the end of 2021. It, however, needs over 14 billion doses as soon as possible to vaccinate its entire adult population. This is almost three times the number of vaccines the world was producing in the pre-pandemic period for other diseases, as per vaccine alliance GAVI.
A worried pharmaceutical industry met on March 8 and 9 at the Global COVID-19 Vaccine Supply Chain and Manufacturing Summit in London, UK, to iron out production glitches and distribution snags in the vaccination drive. “We must urgently work together to prevent shortages from slowing the delivery of the vaccines we need in order to end the pandemic,” said Richard Hatchett, chief executive of the Coalition for Epidemic Preparedness Innovations (CEPI), a non-governmental organisation based in Oslo, Norway, at the summit.
This story is from the April 16, 2021 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the April 16, 2021 edition of Down To Earth.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
In leading role again
MOVIES AND WEB SERIES ARE ONCE AGAIN BEING SET IN RUSTIC BACKGROUNDS, INDICATING A RECONNECT BETWEEN CINEMA AND THE COUNTRYSIDE
One Nation One Subscription comes at a huge cost
As top US universities scrap big deals with top scientific publishers, India’s ONOS scheme seems flawed and outdated
Return of Rambhog
Bid to revive and sell the aromatic indigenous paddy variety has led to substantial profits for farmers in Uttar Pradesh's Terai region
Scarred by mining
Natural springs of Kashmir drying up due to illegal riverbed mining
Human-to-human spread a mutation away
CANADA IN mid-November confirmed its first human case of avian influenza, with a teenager in the British Columbia being hospitalised after contracting the H5N1 virus that causes the disease. The patient developed a severe form of the disease, also called bird flu, and had respiratory issues. There was no known cause of transmission.
True rehabilitation
Residents of Madhya Pradesh's Kakdi village take relocation as an opportunity to undertake afforestation, develop sustainable practices
INESCAPABLE THREAT
Chemical pollution is the most underrated and underreported risk of the 21st century that threatens all species and regions
THAT NIGHT, 40 YEARS AGO
Bhopal gas disaster is a tragedy that people continue to face
A JOKE, INDEED
A CONFERENCE OF IRRESPONSIBLE PARTIES THAT CREATED AN OPTICAL ILLUSION TO THE REALITY OF A NEW CLIMATE
THINGS FALL APART
THE WORLD HAS MADE PROGRESS IN MITIGATING EMISSIONS AND ADAPTING TO CLIMATE IMPACTS. BUT THE PROGRESS REMAINS GROSSLY INADEQUATE
